EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Riboflavin–Ceria Nanoparticles Induce ROS-Driven Mitochondrial Dysfunction in Breast Cancer

Anongnat Wongpan, Napasorn Tana-atsawapon, Sopon Nuchpun, Chayanee Laowittawat, Patraporn Luksirikul, Kobporn Boonnak, Onrapak Reamtong, Sarawut Jitrapakdee, Kanlaya Prapainop

ACS Omega · 09.11.2026

DOI: 10.1021/acsomega.6c05195 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Omega, online erschienen am 09.11.2026. Verfasst von Anongnat Wongpan und 8 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Kasetsart University, Mahidol University, Kasetsart University Research and Development Institute.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cerium oxide nanoparticles (CeO2 NPs) are redox-active nanomaterials with emerging potential in cancer therapy, although their limited cytotoxicity and insufficient mechanistic understanding hinder clinical application. Here, we developed riboflavin-functionalized CeO2 nanoparticles (Rf-CeO2) to enhance photodynamic anticancer efficacy via controlled reactive oxygen species (ROS) generation and mitochondrial targeting. Rf conjugation improves nanoparticle stability and enables photodynamic activation under UV irradiation leading to elevated intracellular oxidative stress. In MDA-MB-231 breast cancer cells, Rf-CeO2 exhibits significantly enhanced cytotoxicity compared to pristine CeO2, inducing dose-dependent cell death and apoptosis. This effect is markedly potentiated by UV exposure, consistent with increased ROS-mediated oxidative stress. Proteomic analysis identifies 60 differentially expressed proteins, revealing disruptions of metabolic pathways, protein synthesis, and DNA repair. Notably, citrate synthase (CS), a key enzyme in the tricarboxylic acid cycle, is significantly downregulated and associated with poor prognosis in breast cancer. Functional validation using Seahorse Mito Stress and TMRM assays confirms mitochondrial dysfunction, including impaired oxidative phosphorylation, reduced ATP production, and loss of membrane potential. Overall, these results demonstrate that Rf-CeO2 acts as an effective photodynamic nanoplatform that induces cancer cell death through synergistic ROS generation and mitochondrial metabolic disruption. This study provides new proteomic insights into ceria-based nanotherapeutics and highlights citrate synthase as a potential therapeutic target for breast cancer.

Förderung

  • Kasetsart University
  • Mahidol University
  • Kasetsart University Research and Development Institute

Zitieren

APA

Wongpan, A., Tana-atsawapon, N., Nuchpun, S., Laowittawat, C., Luksirikul, P., Boonnak, K., Reamtong, O., Jitrapakdee, S., & Prapainop, K. (2026). Riboflavin–Ceria Nanoparticles Induce ROS-Driven Mitochondrial Dysfunction in Breast Cancer. ACS Omega. https://doi.org/10.1021/acsomega.6c05195

Vancouver

Wongpan A, Tana-atsawapon N, Nuchpun S, Laowittawat C, Luksirikul P, Boonnak K, et al. Riboflavin–Ceria Nanoparticles Induce ROS-Driven Mitochondrial Dysfunction in Breast Cancer. ACS Omega. 2026. doi:10.1021/acsomega.6c05195

BibTeX
@article{Wongpan2026,
  author = {Wongpan, Anongnat and Tana-atsawapon, Napasorn and Nuchpun, Sopon and Laowittawat, Chayanee and Luksirikul, Patraporn and Boonnak, Kobporn and Reamtong, Onrapak and Jitrapakdee, Sarawut and Prapainop, Kanlaya},
  title = {Riboflavin–Ceria Nanoparticles Induce ROS-Driven Mitochondrial Dysfunction in Breast Cancer},
  journal = {ACS Omega},
  year = {2026},
  doi = {10.1021/acsomega.6c05195}
}
Kostenlos starten →